31
Participants
Start Date
July 19, 2019
Primary Completion Date
August 18, 2022
Study Completion Date
August 18, 2022
INBRX-101/rhAAT-Fc
INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT) Fc fusion protein (rhAAT-Fc).
University of Florida College of Medicine, Gainesville
University of Miami, Miami
Indiana University, Indianapolis
Hannibal Clinic, Hannibal
UC Davis School of Medicine, Sacramento
The New Zealand Respiratory and Sleep Institute, Auckland
Christchurch Clinical Studies Trust Ltd, Christchurch
Waikato Respiratory and Gastro Research Unit, Hamilton
University of Cambridge, Cambridge
University Hospital Birmingham NHS Foundation Trust, Birmingham
Lead Sponsor
Inhibrx Biosciences, Inc
INDUSTRY